Last reviewed · How we verify

Morphine IV (rescue)

Hospital Central Dr. Luis Ortega · FDA-approved active Small molecule

Morphine binds to opioid receptors in the central nervous system to block pain signal transmission and provide analgesia.

Morphine binds to opioid receptors in the central nervous system to block pain signal transmission and provide analgesia. Used for Acute severe pain (rescue/breakthrough pain), Post-operative pain, Acute myocardial infarction-related pain.

At a glance

Generic nameMorphine IV (rescue)
Also known asBoth groups received Morphine IV (rescue)
SponsorHospital Central Dr. Luis Ortega
Drug classOpioid analgesic
TargetMu-opioid receptor (μ-OR)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Morphine is a mu-opioid receptor agonist that acts on opioid receptors in the brain and spinal cord to modulate pain perception and emotional response to pain. When administered intravenously as a rescue medication, it provides rapid onset analgesia for acute, severe pain. The drug also produces sedation and anxiolysis, making it suitable for acute pain management in hospital settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: